CLINICAL_TRIALS
trial_result
· 2021-09-17
Clinical Trial Update: Ibrance Real World Insights
Summary
A real-world evidence study of palbociclib (Ibrance) in breast cancer has completed and posted results as of September 17, 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Malignant Neoplasm of Breast | Status: COMPLETED | Results posted: 2021-09-17